Endocrine therapy initiation and overall survival outcomes with omission of radiation therapy in older Medicare patients with early‐stage hormone‐receptor‐positive breast cancer
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.5488
Abstract: Guidelines allow for the omission of radiotherapy in older women with early‐stage, hormone‐receptor‐positive breast cancer, given that the patients receive adequate endocrine therapy (ET). However, the initiation of ET and survival outcomes after forgoing radiation… read more here.
Keywords: stage hormone; early stage; receptor positive; hormone receptor ... See more keywords
Inadequate Ovarian Function Suppression with GnRH Agonists and Subsequent Bilateral Salpingo-Oophorectomy Revealing Ovarian Stromal Hyperplasia in a Premenopausal Woman with Early-Stage, Hormone Receptor-Positive Breast Cancer: A Case Report
Sign Up to like & getrecommendations! Published in 2025 at "Case Reports in Oncology"
DOI: 10.1159/000546479
Abstract: Abstract Background: A current standard treatment for pre- or perimenopausal women with high-risk early-stage, hormone receptor-positive breast cancer who have undergone definitive surgery is adjuvant treatment with ovarian function suppression (OFS) with a GnRH agonist… read more here.
Keywords: breast cancer; cancer; hormone receptor; early stage ... See more keywords